強気
$74.58
シナリオ価格
$92.410
+0.961 (+1.04%)終値時点
Unum Group is a provider of financial protection benefits in the United States and the United Kingdom. The Company offers disability, life, accident, critical illness, dental and vision, and other related services. Its segments include Unum US, Unum International, and Colonial Life. The Unum US segment comprises group disability, group life and accidental death and dismemberment, and supplemental and voluntary lines of business. It includes long-term and short-term disability, medical stop-loss, and fee-based service products. The Unum International segment includes insurance for group long-term disability, group life, and supplemental lines of business which include dental, individual disability, and critical illness products. The Colonial Life segment includes the accident, sickness, and disability product line, life product line, and cancer and critical illness product line. Its products are marketed to employees, on both a group and an individual basis.
Unum Group appears to be a good buy right now due to its current price of $91.67 being below the analyst price target of $109 from Barclays, indicating a potential upside of 18.8%. Additionally, the forward P/E ratio of 8.489 suggests the stock is undervalued compared to its earnings potential. The main risk is the cautious full-year guidance for after-tax adjusted operating income per share, which is set at $8.60 to $8.90, slightly below the consensus midpoint of $8.78, indicating potential headwinds in earnings expectations.
BofA
$92
2026-10-12
BofA
2026-10-12
目標株価
$92
Barclays
$109
2026-10-07
Barclays
2026-10-07
目標株価
$109
Morgan Stanley
$92
2026-08-24
Morgan Stanley
2026-08-24
目標株価
$92
JPMorgan
$98
2026-08-03
JPMorgan
2026-08-03
目標株価
$98
JPMorgan
$101
2026-07-21
JPMorgan
2026-07-21
目標株価
$101
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

Unum Group Declares Quarterly Dividend of $0.505

Unum Group to Release Q3 2026 Earnings on November 3

Unum Insurance Group Receives AM Best Rating Affirmation

Unum Group Q2 2026 Earnings Call Insights

Unum Group Q2 Earnings Exceed Expectations Despite Lower Guidance
Unum Group is a provider of financial protection benefits in the United States and the United Kingdom. The Company offers disability, life, accident, critical illness, dental and vision, and other related services. Its segments include Unum US, Unum International, and Colonial Life. The Unum US segment comprises group disability, group life and accidental death and dismemberment, and supplemental and voluntary lines of business. It includes long-term and short-term disability, medical stop-loss, and fee-based service products. The Unum International segment includes insurance for group long-term disability, group life, and supplemental lines of business which include dental, individual disability, and critical illness products. The Colonial Life segment includes the accident, sickness, and disability product line, life product line, and cancer and critical illness product line. Its products are marketed to employees, on both a group and an individual basis. It operates in the Financials sector (ACCIDENT & HEALTH INSURANCE industry).
Unum Group appears to be a good buy right now due to its current price of $91.67 being below the analyst price target of $109 from Barclays, indicating a potential upside of 18.8%. Additionally, the forward P/E ratio of 8.489 suggests the stock is undervalued compared to its earnings potential. The main risk is the cautious full-year guidance for after-tax adjusted operating income per share, which is set at $8.60 to $8.90, slightly below the consensus midpoint of $8.78, indicating potential headwinds in earnings expectations.
13 analysts cover UNM: 3 rate it Buy, 7 Hold and 3 Sell. The average price target is 94.00.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。